Mainboard

IPO ·

NSE, BSE

Paras Healthcare Ltd

Listed

Runs a chain of eight multi-specialty hospitals (about 2,200 beds) across North India, Bihar and Jharkhand.

Issue details

Price band

₹660 – ₹693

Face value

₹1

Lot size

21 shares

Minimum investment

₹14,553

Issue size

₹1,450 Cr

Fresh issue

₹500 Cr

Offer for sale

₹950 Cr

Issue type

Book Built

Exchange

NSE, BSE

Key dates

Opens

21 Oct 2026

Closes

23 Oct 2026

UPI mandate cut-off

5:00 PM on 23 Oct 2026

Allotment

26 Oct 2026

Refunds

27 Oct 2026

Shares in demat

27 Oct 2026

Listing

28 Oct 2026

Subscription and listing

Subscription

2.34x

Listing price

₹720

Registrar

MUFG Intime India Pvt Ltd

Lead manager

JM Financial, BofA Securities India, Nuvama Wealth Management

Subscription by category

QIB (Ex Anchor)

3.25x

NII

0.69x

bNII (> ₹10L)

0.62x

sNII (< ₹10L)

0.84x

Retail

2.10x

Total

2.34x

Total applications

1,46,612

Anchor investors

Amount raised

₹652.50 Cr

Bid date

19 Oct 2026

50% lock-in ends

24 Nov 2026

Rest lock-in ends

23 Jan 2027

Listing day

Issue price

₹693

Open

₹720.00

High

₹748.85

Low

₹706.00

Day close

₹735.60

Listing gain at open

+3.90%

Issue structure

Shares reserved per category and share of the total issue

QIB

1,56,92,640

75.00%

Anchor Investor

94,15,584

45.00%

QIB (Ex. Anchor)

62,77,056

30.00%

NII

31,38,528

15.00%

bNII > ₹10L

20,92,352

10.00%

sNII < ₹10L

10,46,176

5.00%

Retail

20,92,352

10.00%

Total

2,09,23,520

100.00%

Finaccle’s quick read

Avoid

Net losses in FY24 and FY25 before a ₹43.83 Cr profit in FY26, debt/equity of 3.53, and ₹950 Cr of the ₹1,450 Cr issue is OFS.

A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.

About the company

Paras Healthcare runs the Paras Health chain of multi-specialty hospitals in North India, Bihar and Jharkhand. It has 8 hospitals with 2,211 beds in cities such as Gurugram, Patna, Panchkula, Kanpur and Ranchi, focused on cardiac, cancer, neuro, gastro, ortho and renal care. It plans to add hospitals in Gurugram and Ludhiana to reach 3,011 beds by March 2028.

Founded

1987

1987

Promoters

Dharminder Kumar Nagar

Dharminder Kumar Nagar

Products and segments

Tertiary and quaternary hospital care; CONGOR specialties (cardiac, oncology, neuro, gastro, ortho, renal) were 75.30% of FY26 revenue

Tertiary and quaternary hospital care; CONGOR specialties (cardiac, oncology, neuro, gastro, ortho, renal) were 75.30% of FY26 revenue

Promoter holding

72.8% pre-issue; 63.95% post-issue

72.8% pre-issue; 63.95% post-issue

Financial performance

Restated figures in ₹ crore, latest period first

₹ crore, latest first. Full table on desktop.

Period

Total income

Income

EBITDA

PAT

Net worth

Borrowings

Debt

Assets

Q1 FY27 (Jun 2026)

Q1 FY27 (Jun 2026)

478.75

478.75

113.48

49.68

49.68

444.96

1429.49

1429.49

2202.88

FY26

FY26

1628.78

1628.78

335.58

43.83

43.83

394.94

1393.86

1393.86

2071.14

FY25

FY25

1314.21

1314.21

156.46

-57.98

-57.98

280.49

1232.12

1232.12

1810.45

FY24

FY24

1151.02

1151.02

154.41

-15.33

-15.33

338.51

923.92

923.92

1477.66

ROE

12.98%

ROCE

10.76%

Debt / equity

3.53

PAT margin

2.69%

P/E post issue

37.72

Market cap

₹7,498.34 Cr

Use of IPO money

Prepayment/repayment of borrowings

₹320.90 Cr

Investment in subsidiary PMHPL

₹54.10 Cr

General corporate purposes

₹101.11 Cr

Issue expenses

₹66.37 Cr

Strengths

✓

Established regional hospital brand with 2,211 beds

✓

Focus on high-value specialties driving three-quarters of revenue

✓

Income up about 24% in FY26 with improving EBITDA

✓

Clear bed-addition pipeline to 3,011 beds by FY28

Risks to watch

!

Debt/equity of 3.53 with borrowings near ₹1,394 Cr

!

Losses in FY24 and FY25; only turned profitable in FY26

!

Thin FY26 PAT margin of 2.69%

!

OFS of ₹950 Cr is about two-thirds of the ₹1,450 Cr issue

!

Pre-IPO P/E of about 160x

Planning to take your own company public?

Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.

Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.

Last updated:

Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.